Navigation Links
Novel pathway regulates timing of brain cell development

Brain formation involves the carefully timed production of different types of nerve cells by neural stem cells: neurons are produced first, then astrocytes. Making too much of one kind of cell and too little of another at a given time could lead to brain malformations. In the October 6 issue of Cell, researchers in the Neurobiology Program at Children's Hospital Boston report discovering a new molecular pathway that influences the timing of nerve-cell production.

The pathway--which acts through a novel and unexpected mechanism--inhibits production of astrocytes during the early stages of brain development, thereby favoring the production of neurons. (Astrocytes provide structural and functional support to neurons, but can also regulate their differentiation.) Children's neurobiologist Gabriel Corfas, PhD, senior investigator on the study, says the discovery could have implications for diseases such as Alzheimer's disease, schizophrenia and autism.

One key component of the pathway is a protein called erbB4 that straddles the outer membrane of the neural stem cell. Corfas's team showed that mice lacking erbB4 produced astrocytes earlier in embryonic development than normal. ErbB4 is activated by another protein called neuregulin 1 (NRG1), and then is cut in two by a third critical protein called presenilin, the researchers showed. The half of erbB4 that resides inside the cell--a protein called E4ICD--then joins with other proteins in the cell and travels to the cell nucleus. "Once in the nucleus, E4ICD represses genes that trigger astrocyte production, and thereby inhibits astrocyte formation," explains S. Pablo Sardi, PhD, a postdoctoral fellow at Children's and the study's first author.

Previous studies have found presenilin activity to be altered in Alzheimer's disease, and that erbB4 is abundant around the plaques found in Alzheimer's patients' brains. Taken together, the evidence suggests that presenilin's role in Alzheimer's may have to do, in part, with its effects on erbB4 activity--an effect that was previously unrecognized. ErbB4 signaling also regulates neuronal function and survival, processes that have been implicated in Alzheimer's pathology, the researchers note.

"Our findings raise the intriguing possibility that defects in presenilin-mediated erbB4 signaling could be implicated in the early stages of Alzheimer's disease," Corfas says. "Further studies of erbB4 nuclear signaling could provide important insights into the causes of neurodegeneration."

In addition, the genes for both NRG1 and erbB4 have been linked to schizophrenia. Corfas speculates that premature formation of astrocytes resulting from altered functioning of these genes causes subtle malformations in the brain's circuitry. "Changes in the timing in which different neural cells are produced could lead to alterations in brain wiring," he says. "This would lead to alterations in cognitive function such as those seen in schizophrenia--which is now considered to be a developmental disorder--and potentially in other diseases such as autism."


'"/>

Source:Children's Hospital Boston


Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. Novel Enzyme Shows Potential As An Anti-HIV Target
5. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
6. Discovery Could Lead To Novel Approaches In HIV Treatment
7. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
8. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
9. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
10. Novel live reporting system to track cells
11. Field of beams - Novel system uses polarized light pulses to reveal crop health
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
Breaking Biology News(10 mins):
(Date:6/22/2017)... ... 2017 , ... Building on the success of the inaugural RAADfest last year, ... latest developments in radical life extension. RAADfest combines cutting edge science presented for a ... personal development, making it the largest most comprehensive and inclusive super longevity event in ...
(Date:6/22/2017)... ... June 22, 2017 , ... Tunnell Consulting’s ... biopharma and life sciences industries, continue to be in demand for their insights ... will be speaking on “The State of Information Governance in the Biopharmaceutical Industry” ...
(Date:6/20/2017)... ... June 20, 2017 , ... CTNext ... of directors has formed a Higher Education Entrepreneurship Advisory Committee to implement the ... presidents and other high-ranking representatives from 35 higher education institutions across the state ...
(Date:6/20/2017)... ... June 20, 2017 , ... National executive search firm, Slone ... assay development and biomarker expertise, as VP of Scientific Affairs at Cambridge Biomedical. ... bio-analytical assay development and sample testing services. The organization acts as a leading ...
Breaking Biology Technology: